ID   LPS510
AC   CVCL_V414
DR   cancercelllines; CVCL_V414
DR   Cell_Model_Passport; SIDM01795
DR   DepMap; ACH-001804
DR   Wikidata; Q54902994
RX   PubMed=23549872;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Fletcher J.A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
ST   Source(s): DepMap=ACH-001804
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12,14
ST   D18S51: 14,16
ST   D21S11: 29
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 17
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 12
//
RX   PubMed=23549872; DOI=10.1158/1078-0432.CCR-12-2641;
RA   Huang H.-Y., Wu W.-R., Wang Y.-H., Wang J.-W., Fang F.-M., Tsai J.-W.,
RA   Li S.-H., Hung H.-C., Yu S.-C., Lan J., Shiue Y.-L., Hsing C.-H.,
RA   Chen L.-T., Li C.-F.;
RT   "ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant
RT   loss via epigenetic DNA methylation confers aggressive phenotypes,
RT   negative prognostic impact, and therapeutic relevance.";
RL   Clin. Cancer Res. 19:2861-2872(2013).
//